Cordyceps Sunshine Biotech Holdings (RAJAF) Cost of Revenue (2023)

Cordyceps Sunshine Biotech Holdings (RAJAF) recorded quarterly Cost of Revenue of $30842.0 in Q4 2023.

Cordyceps Sunshine Biotech Holdings (RAJAF) Cost of Revenue (2023) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' Cost of Revenue history runs 1 years deep, the most recent figure standing at $30842.0 for Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Paranovus Entertainment Technology 12,507.92 Bn 12,507.92 Bn - -
2 Kraft Heinz 27.05 Bn 22.98 Bn 2.22 Bn 3.83 Bn
3 General Mills 17.93 Bn 17.16 Bn 1.37 Bn 3.07 Bn
4 Jbs 13.56 Bn 8.99 Bn 2.32 Bn 1.30 Bn
5 Hormel Foods 13.29 Bn 12.44 Bn 518.51 Mn 2.45 Bn
6 Mccormick 12.45 Bn 12.85 Bn 708.90 Mn 1.17 Bn
7 Magnum Ice Cream 11.94 Bn 11.47 Bn - -
8 J M Smucker 11.83 Bn 11.77 Bn 862.10 Mn 1.41 Bn
9 Smithfield Foods 9.80 Bn 8.73 Bn 511.00 Mn 3.29 Bn
10 Cordyceps Sunshine Biotech Holdings - - - -

Historic Data

Download Data
DateValue
Dec 31, 2023 30,842.00
Dec 31, 2023 30,842.00